19/11/2024  08:01:06 Var. +0.020 Volume Denaro10:58:21 Lettera10:58:21 Capitalizzazione di mercato Dividend Y. Rapporto P/E
25.420EUR +0.08% 0
Fatturato: 0.000
25.280Quantità in denaro: 500 25.700Quantità in lettera: 500 45.43 bill.EUR - -

Descrizione business

Japan Tobacco Inc. is engaged in the tobacco, pharmaceutical and food industry. The domestic tobacco business, the core business of JT, includes the brands Winston, Camel, MEVIUS and LD. The Group's tobacco business outside Japan operate in more than 70 countries, manufacturing, marketing and selling tobacco products to 120 countries around the world. In addition, into the pharmaceuticals business, JT is active in research and development on glucose and lipid metabolism; virus; immune disorders and inflammation; and bone metabolism. Furthermore, in the food business, JT Group is focused on three business areas: processed foods and seasonings.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Masamichi Terabatake
Consiglio di amministrazione
Hiromasa Furukawa, Kei Nakano, Junichi Fukuchi, Suguru Fujiwara, Nobuhiro Uezawa, Makoto Kakutani, Keisuke Nakagomi, Osamu Hirose, Hiroyuki Fukuda, Kenji Ogura, Hisato Imokawa, Yoshiyuki Mishima, Hisashi Shimobayashi, Yuki Otaki, Takayuki Yamaguchi, Kazuyuki Inui, Igor Dzaja, Koji Shimayoshi
Consiglio di sorveglianza
Mutsuo Iwai, Shigeaki Okamoto, Masamichi Terabatake, Kei Nakano, Yukiko Nagashima, Masato Kitera, Tetsuya Shoji, Hiroko Yamashina, Kenji Asakura, Koji Shimayoshi
 

Dati aziendali

Name: Japan Tobacco Inc.
Indirizzo: 1-1, Toranomon 4-chome,Minato-ku Tokyo 105-6927, Japan
Telefono: +81 3 6636 2914
Fax: -
E-mail: -
Internet: www.jt.com/
Industria: Consumer Goods
Settore: Tobacco
Sub settore: Tobacco
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: -

Rapporti con gli investitori

Name: Nobuya Kato
IR telefono: -
IR Fax: -
IR e-mail: -

Company calendar

CW 7 | 13/02/2025 4th Quarter/Annual Report
CW 19 | 07/05/2025 Interim Report 1st Quarter/3 Months
CW 31 | 31/07/2025 Interim Report 2nd Quarter/6 Months
CW 44 | 30/10/2025 Interim Report 3rd Quarter/9 Months